BioNTech SE (BNTX) 30-day option implied volatility into developing Covid-19 vaccine
Tweet
Share
E-mail
Get Alerts BNTX Hot Sheet
Join SI Premium – FREE
BioNTech SE (NASDAQ: BNTX) 30-day option implied volatility is at 117; compared to its 52-week range of 98 to 185 into developing Covid-19 vaccine.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix (NFLX) call put ratio 2.2 calls to 1 put into quarter results
- Cytokinetics (CYTK) July 100 and January 80 calls active, share price down 3.9%
- Goldman Sachs (GS) call put ratio 1 call to 2 puts into quarter results
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
